Congress Wants Review of Test Fraud As part of a spending bill approved by Congress recently, there is a small provision that hints at future review of clinical laboratory tests by the US Department of Health and Human Services’ Office of Inspector General (OIG). Bill number H.R.7148 (Consolidated Appropriations Act of 2026) calls for the […]
Office of Inspector General Briefs
- By Scott Wallask
- > From the Volume XXXIII, No. 2 - February 9, 2026 Issue
- Tags: Congress, Consolidated Appropriations Act of 2016, false claims act, genetic assays, HHS, medicare fraud, Medicare Part B, Office of Inspector General, OIG, PAMA, Protecting Access to Medicare Act of 2014, Semiannual Report to Congress, telemarketing, the dark report, US Department of Health and Human Services
